To comply with Canadian International Pharmacy Association regulations you are permitted to order a 3-month supply or the closest package size available based on your personal prescription. read more
(oh'' loe da' ter ol)In a large clinical study, more people who used an asthma medication similar to olodaterol experienced more severe episodes of asthma that needed to be treated in a hospital or caused death than patients who did not use the medication. Use of olodaterol inhalation may increase the risk of serious asthma problems or death in people who have asthma. Olodaterol inhalation has not been approved by the Food and Drug Administration (FDA) to treat asthma. There is not enough information to tell whether olodaterol inhalation increases the risk of death in people who have chronic obstructive pulmonary disease (COPD; a group of lung diseases, which includes chronic bronchitis and emphysema). Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with olodaterol inhalation and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the manufacturer's website to obtain the Medication Guide. Talk to your doctor about the risks of using olodaterol oral inhalation.
The content on this page is for informational and educational purposes only and does not constitute professional medical advice. Patients should not use the information presented on this page for diagnosing a health-related issue or disease. Before taking any medication or supplements, patients should always consult a physician or qualified healthcare professional for medical advice or information about whether a drug is safe, appropriate or effective.